Randomized controlled phase I/II study to investigate immune stimulatory effects by low dose radiotherapy in primarily operable pancreatic cancer
<p>Abstract</p> <p>Background</p> <p>The efficiencies of T cell based immunotherapies are affected by insufficient migration and activation of tumor specific effector T cells in the tumor. Accumulating evidence exists on the ability of ionizing radiation to modify the t...
Main Authors: | Debus Juergen, Buechler Markus W, Tjaden Christine, Koch Moritz, Rochet Nathalie, Reissfelder Christoph, Bonertz Andreas, Roeder Falk FF, Klug Felix, Winnenthal Hubertus, Timke Carmen, Werner Jens, Beckhove Philipp, Weitz Jürgen, Huber Peter E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/11/134 |
Similar Items
-
Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC
by: Roeder Falk, et al.
Published: (2012-03-01) -
Aggressive local treatment containing intraoperative radiation therapy (IORT) for patients with isolated local recurrences of pancreatic cancer: a retrospective analysis
by: Roeder Falk, et al.
Published: (2012-07-01) -
Intensity modulated radiotherapy (IMRT) in benign giant cell tumors -- a single institution case series and a short review of the literature
by: Thieke Christian, et al.
Published: (2010-02-01) -
Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer
by: Timke Carmen, et al.
Published: (2011-03-01) -
Intraoperative Electron Radiation Therapy (IOERT) in the management of locally recurrent rectal cancer
by: Roeder Falk, et al.
Published: (2012-12-01)